Dipyridamole
Showing 26 - 50 of 164
Cirrhosis, Hypertension, Status;Splenectomy Trial in Yangzhou (Warfarin, Dipyridamole, Aspirin)
Completed
- Cirrhosis
- +3 more
- Warfarin
- +3 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 28, 2019
Ischemic Heart Disease Trial in New York (Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary
Recruiting
- Ischemic Heart Disease
- Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
-
New York, New YorkGramercy Cardiac Diagnostic Services
Aug 17, 2021
Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor
Active, not recruiting
- Cardiovascular Disease
- +3 more
- Comprehensive therapy program for risk factor modification
-
Houston, TexasWeatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022
Cardiac Disease Trial in New York (Imaging software for 4 dimensional images for Cardiac MRI)
Active, not recruiting
- Cardiac Disease
- Imaging software for 4 dimensional images for Cardiac MRI
-
New York, New YorkNorthwell Health Imaging at Greenwich Village: a Division of Len
Oct 25, 2022
Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
Completed
- Acute Coronary Syndrome
- +3 more
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care drugs
-
Multiple Locations, SwedenMany Locations
Sep 22, 2021
Angina Pectoris Trial in Leuven (Cardiac computed tomography)
Unknown status
- Angina Pectoris
- Cardiac computed tomography
-
Leuven, BelgiumUniversity Hospitals Leuven
Nov 16, 2020
Heart Failure in Patients With Myocardial Infarction.
Recruiting
- Heart Failure
- Acute Myocardial Infarction
- Possible risk factors of heart failure
-
Beijing, ChinaJian Liu
Feb 25, 2023
Myocardial Perfusion Trial in Pouso Alegre
Completed
- Myocardial Perfusion
-
Pouso Alegre, Minas Geral, BrazilCorpus Imagens
Nov 3, 2020
Cirrhosis, Hypertension, Venous Thrombosis Trial in Yangzhou (Warfarin, Dipyridamole, Aspirin)
Unknown status
- Cirrhosis
- +3 more
- Warfarin
- +3 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Dec 30, 2018
Potential Adverse Outcomes in Routine Clinical Practice
Completed
- Venous Thrombosis
- +3 more
- Rivaroxaban (Xarelto, Bay59-7939)
- Standard of care
-
Multiple Locations, Germany(unnamed)
Oct 21, 2021
Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy Trial in Benevento (ABCDE-Stress Echo, SE diastolic
Recruiting
- Coronary Artery Disease
- +6 more
- ABCDE-Stress Echo
- +3 more
-
Benevento, ItalyFatebenefratelli Hospital
Oct 18, 2021
Potential Adverse Outcomes in Routine Clinical Pratice
Completed
- Venous Thrombosis
- +3 more
- Rivaroxoban (Xarelto, Bay59-7939)
- Standard of care
-
Multiple Locations, Netherlands(unnamed)
Sep 22, 2021
Potential Adverse Outcomes in Routine Clinical Pratice (UK)
Completed
- Venous Thrombosis
- +3 more
- Rivaroxaban (Xarelto, Bay59-7939)
- +2 more
-
Multiple Locations, United Kingdom(unnamed)
Sep 22, 2021
New Cardiac Imaging in Patients With Chest Pain
Terminated
- Cardiology
- +2 more
- CT-FFR and CTP
-
Lancaster, PennsylvaniaPenn Medicine / Lancaster General Hospital
Dec 22, 2022
Pharmacological Stress Agent Before SPECT
Completed
- Myocardial Perfusion Imaging
- collect examination time, functional and clinical tolerability
-
Bron, FranceLyon civil Hospital - Est Hospital Complexe - Nuclear Medicine S
Apr 12, 2018
Diabetes, Type 2 Trial in Brussels (Dapagliflozin 10 mg Tab, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Dapagliflozin 10 mg Tab
- Placebo
-
Brussels, Bruxelles-Capitale, Région de;Brussels Hoofdstedelijk Gewest, BelgiumCHU Saint Pierre
Aug 30, 2022
Coronary Artery Disease Trial in Nashville (Adenosine)
Completed
- Coronary Artery Disease
-
Nashville, TennesseeAutonomic Dysfunction Center
Feb 27, 2018
End-stage Kidney Disease Trial in Kingston, London, Ottawa (Vitamin K1, Microcrystalline Methylcellulose)
Completed
- End-stage Kidney Disease
- Vitamin K1
- Microcrystalline Methylcellulose
-
Kingston, Ontario, Canada
- +2 more
Jun 24, 2021
Restless Legs Syndrome Trial in Peoria (Magnesium Citrate)
Recruiting
- Restless Legs Syndrome
- Magnesium Citrate
-
Peoria, IllinoisOSF Healthcare Illinois Neurological Institute
Jun 10, 2021
Coronary Heart Disease, Metabolic Syndrome, Diabetes Trial in Boston (PET scan, Echocardiogram)
Completed
- Coronary Heart Disease
- +2 more
- PET scan
- Echocardiogram
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 11, 2020
Coronary Artery Disease Trial in Farmington (dipyridamole)
Terminated
- Coronary Artery Disease
- dipyridamole
-
Farmington, ConnecticutUCONN Health Center
Mar 14, 2018
Plasma Transfusion in Major Vascular Surgery
Completed
- Aortic Aneurysm, Abdominal
- Arterial Occlusive Diseases
- Plasma transfusion
-
Slagelse, Region Zealand, DenmarkSlagelse Hospital
Jan 25, 2021
Microvascular Angina Trial in Jinan (Compound Danshen Dropping Pills, Placebo)
Recruiting
- Microvascular Angina
- Compound Danshen Dropping Pills
- Placebo
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Oct 15, 2023
Refractory Angina, Chronic Stable Angina Trial in Belgrade (Physical rehabilitation, Heparin, Placebo)
Completed
- Refractory Angina
- Chronic Stable Angina
- Physical rehabilitation
- +2 more
-
Belgrade, SerbiaClinical Centre of Serbia
May 12, 2020
Henoch-Schönlein Purpura Nephritis Trial in Zhengzhou (Glycosides Of Tripterygium Wilfordii Hook(GTW), Sulfotanshinone Sodium
Unknown status
- Henoch-Schönlein Purpura Nephritis
- Glycosides Of Tripterygium Wilfordii Hook(GTW)
- +7 more
-
Zhengzhou, Henan, China
- +1 more
Jul 7, 2018